The future of population-based postmarket drug risk assessment: A regulator's perspective

T. A. Hammad, G. A. Neyarapally, S. Iyasu, J. A. Staffa, G. Dal Pan

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'The future of population-based postmarket drug risk assessment: A regulator's perspective'. Together they form a unique fingerprint.

Medicine & Life Sciences